Skip to main content
QD Clinic - RA and DVT
Italian IBD clinic with 90 IBD Vedolizumab Tx pts, 8%(11) developed severe enthesitis (4 Multifocal, 6 unifocal). Sxs af

Dr. John Cush RheumNow

5 years 7 months ago
Italian IBD clinic with 90 IBD Vedolizumab Tx pts, 8%(11) developed severe enthesitis (4 Multifocal, 6 unifocal). Sxs after mean 46 wks, CRP=5.1 mg/dl, majority HLA-B27 negative; confirmed by PD/UA in 7 - 4/7 developed post-inflam entheseal calcifications https://t.co/uwAJM8giBX
Metanalysis of patients with diffuse alveolar hemorrhage (DAH), show this to be a rare and life-threatening complication of systemic lupus erythematosus (SLE), that is more apt to affect older, severe lupus patients with active infection.
Annals of Internal Medicine reports treating advanced melanoma with immune checkpoint inhibitors (ICI) in patients with pre-existing autoimmune disease (AID) was as effective and safe in those with AID compared to those without AID, although severe colitis occurred more frequently among patients with preexisting inflammatory bowel disease.
Common mucocutaneous findings in 35 kids w/ MIS-C & COVID: 1) conjunctival injection (21), palmoplantar erythema (18

Dr. John Cush RheumNow

5 years 7 months ago
Common mucocutaneous findings in 35 kids w/ MIS-C & COVID: 1) conjunctival injection (21), palmoplantar erythema (18), lip hyperemia (17), periorbital erythema/edema (7), strawberry tongue (8), & malar erythema (6) https://t.co/mcSOXtXaEh
RWCS Highlights - Day 4 from Dr. Rachel Tate ( @uptotate)

-Novel Therapies Year in Review (RA, SLE, OA)
-Novel concept

Dr. John Cush RheumNow

5 years 7 months ago
RWCS Highlights - Day 4 from Dr. Rachel Tate ( @uptotate) -Novel Therapies Year in Review (RA, SLE, OA) -Novel concepts in Pediatric Rheumatology -TeleRheumatology Update: Post-COVID, Pre-?? https://t.co/JoTV25suxD https://t.co/Id19zgRT37
ACR and Three Societies Agree on HCQ Eye Safety

Four major medical societies issued a joint statement of principles on

Dr. John Cush RheumNow

5 years 7 months ago
ACR and Three Societies Agree on HCQ Eye Safety Four major medical societies issued a joint statement of principles on safe use of hydroxychloroquine from the perspective of ocular toxicity. https://t.co/3ALK3MpOen https://t.co/SzScNXgoqn
MIRROR Study: Pegloticase With Methotrexate in Uncontrolled Gout

Botson et al has reported that the combination of meth

Dr. John Cush RheumNow

5 years 7 months ago
MIRROR Study: Pegloticase With Methotrexate in Uncontrolled Gout Botson et al has reported that the combination of methotrexate (MTX) and IV pegloticase is safe and effective in patients with uncontrolled gout. https://t.co/DRkIMOAhs4 https://t.co/2dft1QjC6E
As another year at RWCS in Maui wrapped up, I’m so thankful I had the opportunity to participate remotely. Here are my day 4 #RWCS2021 pearls from the Novel Therapies Year in Review (RA, SLE, OA); novel concepts in pediatric rheumatology; and post-COVID telerheumatology sessions.
ACR and Three Societies Agree on HCQ Eye Safety
  • MedPage Today
Four major medical societies issued a joint statement of principles on safe use of hydroxychloroquine from the perspective of ocular toxicity.
30 #RA pts treated w/ tofacitinib x 12 mos w/ signif improvement in DAS28, CRP, & HAQ and attenuation of further bon

Dr. John Cush RheumNow

5 years 7 months ago
30 #RA pts treated w/ tofacitinib x 12 mos w/ signif improvement in DAS28, CRP, & HAQ and attenuation of further bone loss, as measured by significantly increased osteocalcin, OPG, and vitamin D3, with decreased CTX levels correlating w/ DXA results https://t.co/RSXL38cJvs
RT @NIH_NIAMS: Dr. Lindsey A. Criswell was sworn in this morning as the new director of NIAMS. https://t.co/4LxsX9Lh1W

NIAMS/NIH/DHHS NIH_NIAMS

5 years 7 months ago
Dr. Lindsey A. Criswell was sworn in this morning as the new director of NIAMS. https://t.co/4LxsX9Lh1W
×